对AKT抑制剂的选择性研究和自由能量计算
Haizhen A Zhong1, David T Goodwin1
1Department of Chemistry, University of Nebraska at Omaha, Omaha, NE 68182, USA.
Molecules (Basel, Switzerland)
|March 28, 2024
概括
开发选择性AKT抑制剂对于癌症治疗至关重要,以尽量减少副作用. 这项研究确定了AKT1和AKT3选择性的关键蛋白质残留物,可能减少与AKT2抑制相关的皮肤毒性.
科学领域:
- 生物化学 生物化学
- 计算化学计算化学
- 药物发现 药物发现 药物发现
背景情况:
- 蛋白激酶B (PKB),也称为AKT,是癌症治疗的关键目标.
- 目前的AKT抑制剂面临的挑战包括不良影响,特别是与AKT2抑制相关的皮肤毒性.
- 选择性抑制AKT异型是必要的,以改善治疗结果和减少毒性.
研究的目的:
- 通过计算识别选择性结合AKT1,AKT2和AKT3异型的关键残留物.
- 引导AKT1选择性或AKT3选择性抑制剂的合理设计.
- 通过节省AKT2抑制来最大限度地降低皮肤毒性.
主要方法:
- 使用施罗丁格共价码头 (CovDock) 进行分子对接模拟.
- 使用基于移动类型 (MT) 的自由能量计算 (ΔG) 来评估约束亲和力.
- 分析了对接数据,以确定参与异型结合的特定氨基酸残留物.
主要成果:
- 对接模拟准确地预测了具有小平均误差的实验结合自由能量.
- 对AKT1 (Asn54, Trp80, Tyr272, Asp274, Asp292),AKT2 (Phe163, Glu279) 和AKT3 (Glu17, Trp79, Phe306, Glu295) 的结合物确定了不同的残留物要求.
- 这些发现为区分AKT异型提供了基础.
结论:
- 计算方法,CovDock和基于MT的 ΔG,对于预测结合的自由能量是有效的.
- 特定的残留物对于选择性结合AKT1,AKT2和AKT3至关重要.
- 这项研究可以为开发更安全,异形选择性AKT抑制剂用于癌症治疗提供信息,减轻AKT2相关的毒性.
相关概念视频
The Equilibrium Binding Constant and Binding Strength
12.9K
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
12.9K
Allosteric Proteins-ATCase
5.7K
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
5.7K
Ligand Binding and Linkage
4.8K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
4.8K
Enzymes
81.5K
Inside living organisms, enzymes act as catalysts for many biochemical reactions involved in cellular metabolism. The role of enzymes is to reduce the activation energies of biochemical reactions by forming complexes with its substrates. The lowering of activation energies favor an increase in the rates of biochemical reactions.
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
81.5K


